BUZZ-Inogen gains after FDA approves airway clearing device

Shares of medical device maker Inogen INGN.O rise 10.6% to $9.49 premarket

Co says its device for clearing mucus from lungs has received FDA 510(k) approval

FDA 510(k) approval is a process where a medical device is shown to be safe and similar to an existing device before it can be sold

The device, SIMEOX 200 Airway Clearance Device, helps improve bronchial drainage in patients with chronic respiratory diseases - INGN

The device is intended for patients who can cough on their own - INGN

Co plans a limited launch of the device at targeted sites in 2025

As of last close, stock has risen 56.3% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))